RapidAI has entered a strategic partnership with Saudi Health Holdings for its AI technology.
Saudi Health is the largest healthcare provider in the Middle East. Through the agreement, RapidAI will deploy its Rapid Enterprise Platform across Saudi Health’s national network of 20 health clusters of hospitals and clinics. The platform includes algorithms to support diagnostics and workflows in neurology, cardiology, vascular, oncology, and orthopedics, RapidAI said.
Rapid Enterprise Platform integrates imaging, reports, and structured clinical data, and provides characterization, quantification, visualization, and longitudinal tracking across disease states and service lines, according to the company.
Saudi Arabian healthcare consulting firm Ascend Solutions will provide on-the-ground operational services, including implementation and training, RapidAI noted.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
